Gerald M. Kenny

3.3k total citations
60 papers, 2.6k citations indexed

About

Gerald M. Kenny is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Gerald M. Kenny has authored 60 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 17 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Gerald M. Kenny's work include Immunotherapy and Immune Responses (15 papers), Prostate Cancer Treatment and Research (14 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). Gerald M. Kenny is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Prostate Cancer Treatment and Research (14 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). Gerald M. Kenny collaborates with scholars based in United States, South Africa and United Kingdom. Gerald M. Kenny's co-authors include Haakon Ragde, Alton L. Boynton, G.P. Murphy, B.A. Tjoa, Gerald P. Murphy, M.J. Troychak, M. Rogers, S.J. Simmons, Michael L. Salgaller and A. Elgamal and has published in prestigious journals such as Cancer, The Journal of Urology and Cellular and Molecular Life Sciences.

In The Last Decade

Gerald M. Kenny

57 papers receiving 2.5k citations

Peers

Gerald M. Kenny
Masanori Noguchi Japan
Haakon Ragde United States
Wolfgang Schultze‐Seemann Germany
Cyrill A. Rentsch Switzerland
Thomas K. Τakayama United States
Karel A. Dicke United States
Kent W. Mouw United States
Michele Mondini France
E. Roy Berger United States
Catherine Lhommé France
Masanori Noguchi Japan
Gerald M. Kenny
Citations per year, relative to Gerald M. Kenny Gerald M. Kenny (= 1×) peers Masanori Noguchi

Countries citing papers authored by Gerald M. Kenny

Since Specialization
Citations

This map shows the geographic impact of Gerald M. Kenny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald M. Kenny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald M. Kenny more than expected).

Fields of papers citing papers by Gerald M. Kenny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald M. Kenny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald M. Kenny. The network helps show where Gerald M. Kenny may publish in the future.

Co-authorship network of co-authors of Gerald M. Kenny

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald M. Kenny. A scholar is included among the top collaborators of Gerald M. Kenny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald M. Kenny. Gerald M. Kenny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Murphy, Gerald P., Abdel‐Aziz A. Elgamal, M.J. Troychak, & Gerald M. Kenny. (2000). Follow-up ProstaScint� scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy. The Prostate. 42(4). 315–317. 26 indexed citations
3.
Simmons, S.J., B.A. Tjoa, M. Rogers, et al.. (1999). GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial. The Prostate. 39(4). 291–297. 59 indexed citations
4.
Tjoa, B.A., S.J. Simmons, A. Elgamal, et al.. (1999). Follow-up evaluation of a phase II prostate cancer vaccine trial. The Prostate. 40(2). 125–129. 121 indexed citations
5.
6.
Murphy, G.P., B.A. Tjoa, S.J. Simmons, et al.. (1999). Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment. The Prostate. 39(1). 54–59. 153 indexed citations
7.
Tjoa, B.A., S.J. Simmons, Victoria Bowes, et al.. (1998). Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. The Prostate. 36(1). 39–44. 207 indexed citations
8.
Salgaller, Michael L., Patricia A. Lodge, Douglas J. Loftus, et al.. (1998). Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA). The Prostate. 35(2). 144–151. 95 indexed citations
9.
Tjoa, B.A., Sheila J. Erickson, Victoria Bowes, et al.. (1997). Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. The Prostate. 32(4). 272–278. 103 indexed citations
10.
Ragde, Haakon, John C. Blasko, Peter Grimm, et al.. (1997). Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer. 80(3). 442–453. 215 indexed citations
11.
Murphy, Gerald P., Robert T. Maguire, Alan W. Partin, et al.. (1997). Comparison of serum PSMA, PSA levels with results of cytogen-356 ProstaScint® scanning in prostatic cancer patients. The Prostate. 33(4). 281–285. 49 indexed citations
12.
Ragde, Haakon, et al.. (1997). Transrectal ultrasound microbubble contrast angiography of the prostate. The Prostate. 32(4). 279–283. 52 indexed citations
13.
Murphy, Gerald P., M.J. Troychak, Oliver E. Cobb, et al.. (1997). Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer. The Prostate. 33(2). 141–146. 16 indexed citations
14.
Murphy, Gerald P., Robert J. Barren, Sheila J. Erickson, et al.. (1996). Evaluation and comparison of two new prostate carcinoma markers: Free-prostate specific antigen and prostate specific membrane antigen. Cancer. 78(4). 809–818. 52 indexed citations
15.
Murphy, G.P., B.A. Tjoa, Haakon Ragde, Gerald M. Kenny, & Alton L. Boynton. (1996). Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. The Prostate. 29(6). 371–380. 328 indexed citations
16.
Murphy, G.P., Eric H. Holmes, Alton L. Boynton, et al.. (1996). Measurement of prostate-specific membrane antigen in the serum with a new antibody. The Prostate. 28(4). 266–271. 31 indexed citations
17.
Tjoa, B.A., Sheila J. Erickson, Robert J. Barren, et al.. (1995). In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy. The Prostate. 27(2). 63–69. 44 indexed citations
18.
Rochon, Yvan, Julius S. Horoszewicz, Alton L. Boynton, et al.. (1994). Western blot assay for prostate‐specific membrane antigen in serum of prostate cancer patients. The Prostate. 25(4). 219–223. 50 indexed citations
19.
Kenny, Gerald M. & W. B. Hutchinson. (1988). Transrectal ultrasound study of prostate. Urology. 32(5). 401–402. 8 indexed citations
20.
Kenny, Gerald M., et al.. (1972). Current Results from Treatment of Stages C and D Bladder Tumors at Roswell Park Memorial Institute. The Journal of Urology. 107(1). 56–59. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masanori Noguchi Breakdown of academic impact, for papers by Haakon Ragde Breakdown of academic impact, for papers by Wolfgang Schultze‐Seemann Breakdown of academic impact, for papers by Cyrill A. Rentsch Breakdown of academic impact, for papers by Thomas K. Τakayama Breakdown of academic impact, for papers by Karel A. Dicke Breakdown of academic impact, for papers by Kent W. Mouw Breakdown of academic impact, for papers by Michele Mondini Breakdown of academic impact, for papers by E. Roy Berger Breakdown of academic impact, for papers by Catherine Lhommé
Rankless by CCL
2026